Keyware Solutions Inc.
Q&A Summary for the Fiscal Year Ending March 2026 Earnings Explanation
Full-year results: Revenue up 7.7% and operating income up 22.8% for the FY ending March 2026, achieving the full-year plan. For FY ending March 2027, planned revenue of JPY 24,000 million and operating income of JPY 1,200 million. Establishment of new subsidiary Keyware Medical and absorption-type merger, expected dividend increase from ¥34 to ¥40, and continuation of shareholder benefits.
Key Figures
- Revenue: Unknown → FY2026 actual disclosed element (up 7.7% YoY)
- FY2027 Revenue: 24,000 million yen
- FY2027 Operating income: 1,200 million yen
AI要約
Financial Highlights
For the year ended March 2026, revenue increased 7.7% year on year and operating income rose 22.8%, achieving the full-year plan. Revenue was driven by growth in the system development business, with expansion in transport, medical, public sector, and IoT-related projects, along with large-scale SI projects and contributions from retail/wholesale-related projects. Ordinary income and net income attributable to parent company shareholders decreased due to impairment of equity-method investments resulting from related party movements and the pullback from the previous year's equity sale gains.
Outlook and Investor Points
For the year ending March 2027, the company projects full-year consolidated revenue of JPY 24,000 million (up 5.6% YoY) and operating income of JPY 1,200 million (up 6.1% YoY), maintaining a path of revenue growth and profit growth. By establishing the subsidiary Keyware Medical and implementing an absorption-type merger, the company aims to expand in the medical healthcare field and continue capturing development demand through DX promotion. Dividends are projected at ¥34 for the year ended March 2026 and ¥40 for the year ending March 2027, with shareholder benefits continued.
Keyware Solutions Co., Ltd.
Company overview · Stock price · Financial data · All IR
